The Influence of Patient Factors on the Population Pharmacokinetics of Colchicine: Implications for Safe and Effective Dosing. [PDF]
Wright DFB +6 more
europepmc +1 more source
Research progress on multidimensional intervention strategies for hyperuricemia: Western medicine, Traditional Chinese Medicine, and emerging therapies. [PDF]
Li X +9 more
europepmc +1 more source
Risk of Hepatotoxicity in Patients With Gout Treated With Febuxostat or Benzbromarone: A Propensity Score-Matched Cohort Study. [PDF]
Sun W +8 more
europepmc +1 more source
The Impact of Perceived Adverse Effects on Medication Changes in Heart Failure Patients [PDF]
Altman +29 more
core +1 more source
Pacific community's perceptions on how to improve uptake of urate-lowering therapy for Pacific gout patients. [PDF]
Ofanoa S +5 more
europepmc +1 more source
Comparison of pharmacokinetic and pharmacodynamic properties of allopurinol and benzbromarone in a quail model of hyperuricemia. [PDF]
Zheng S, Bu Y, Li S, Chen N.
europepmc +1 more source
2024 Update of Chinese Guidelines for Diagnosis and Treatment of Hyperuricemia and Gout Part I: Recommendations for General Patients. [PDF]
Sun M +30 more
europepmc +1 more source
Human genetic evidence supports fibroblast growth factor 21 as a novel therapeutic target for gout. [PDF]
Zhao SS, Cuthbertson DJ, Alam U.
europepmc +1 more source
Knowledge and practice of gout treatment recommendations by primary health care physicians in Saudi Arabia: A cross-sectional study across five different regions. [PDF]
Alharbi S +6 more
europepmc +1 more source

